Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

OB/Gyn > Breast Disorders > Flashcards

Breast Disorders Flashcards

1
Q

A localized collection of inflammatory exudate in the breast tissue?

A

Breast Abscess.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a common cause of a breast abscess?

A

Develops most commonly when mastitis or cellulitis does not respond to Abx treatment; an abscess can also be the first presentation of breast infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology of a Breast Abscess?

A
  1. Uncommon; 0.1% incidence and 3% in women with Abx-treated mastitis.
  2. Incidence ranges from 0.4-11% of lactating mothers.
  3. Occurs more frequently in AAs, obesity,, smokers.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk factors for Breast Abscess?

A
  1. Maternal age >30 yrs.
  2. 1st pregnancy.
  3. Gestational age > 41 wks.
  4. Smoking – only factor assoc. w/abscess recurrence.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the classifications of Non-lactational abscesses?

A
  1. Central due to periductal mastitis.
  2. Peripheral (< central); sometimes assoc. w/underlying conditions – DM, RA, Steroid Tx, Trauma.
  3. Skin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the clinical presentation of a breast abscess?

A
  1. Localized, painful inflammation of the breast with fever and malaise.
  2. Fluctuant, tender, palpable mass.
  3. Time of onset is variable; mastitis and abscess can present together or abscess develops 5-28 days following Tx for mastitis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnosis of a breast abscess?

A
  1. Clinical Dx based on clinical manifestations.
  2. U/S can demonstrate a fluid collection and guide aspiration.
  3. Women lactating, culture of breast milk is useful to guide Abx selection if no pus obtained.
    - -Severe, Hospital acquired or unresponsive to Abx.
  4. Blood cultures warranted in the setting of severe infection, but otherwise not routinely used.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DDx of a breast abscess?

A
  1. Skin abscess overlying breast.
  2. Inflammatory breast cancer or other breast malignancy.
  3. Paget disease of the breast.
  4. Superficial thrombophlebitis of breast (Mondor Dz).
  5. Morphea – localized scleroderma.
  6. Postoperative derma lymphadema.
  7. Radiation-induced dermatitis or fibrosis.
  8. Spontaneous gangrene of breast.
  9. Bite wound.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of a breast abscess?

A

**Depends in part on the state of the overlying skin.

  1. Nonischemic skin – US guided aspiration under local anesthesia.
    - -May have to repeat aspiration Q2-3 days till no collection remains, usually 2-3 aspirations.
  2. Ischemic skin – surgical I and D.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antibiotic management of a breast abscess?

A
  1. Empiric Abx therapy should cover activity of Staph. Aureus.
    - -MRSA not suspected: Dicloxacillin or Cephalexin; clindamycin as alt.
    - -MRSA suspected: Bactrim or Clindamycin.
  2. Severe Infections – Inpatient; Vancomycin.
  3. 10-14 days following drainage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some Abx used in a subareolar breast abscess with a retracted nipple or breast abscess assoc. w/hidradenitis suppurativa?

A

Augmentin, Clindamycin or Dicloxacillin + Metronidazole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the possible anaerobic involved in a subareolar breast abscess with a retracted nipple or breast abscess assoc. w/hidradenitis suppurativa?

A

An anaerobic infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common non-cancerous, benign tumor or mass of the breast?

A

Fibroadenoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What breast disorder accounts for 1/2 of all breast biopsies?

A

Fibroadenoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is contained in a fibroadenoma?

A

Benign solid tumors containing glandular, as well as fibrous tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the epidemiology and cause of fibroadenomas?

A
  1. MC found in women b/t ages 15-35 yrs.
  2. Cause may have a hormonal relationship esp. if they persist during reproductive years, increase in size during pregnancy or w/estrogen therapy, and regress after menopause.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risk factors for a Fibroadenoma?

A
  1. Histologic features of fibroadenoma influence risk of breast cancer.
  2. The risk of subsequent breast cancer is slightly elevate if: complex, adjacent proliferative Dz, FH of breast cancer.
  3. Majority of women with simple fibroadenomas, no risk of developing breast cancer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clinical presentation of fibroadenomas?

A
  1. Lump in the breast, smooth to touch and mobile.
  2. Painless, but can be tender to the touch.
  3. Well-defined, mobile mass on PE.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Evaluation and diagnosis of a fibroadenoma?

A
  1. Imaging – mammogram or U/S to further characterize the lesion.
  2. DEFINITIVE – core biopsy or excision.
  3. Excision mandated if increased in size or symptomatic to r/o malignant change and confirm Dx.
  4. Rapid growth of a lesion raises the suspicion for phyllodes tumor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treatment and management of a fibroadenoma?

A
  1. If < 3 cm, observation; can monitor w/routine breast exams and U/S if changes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is a phyllodes tumor?

A

Rare breast tumors that start in the connective tissue and are most common in women in their 30s and 40s.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

DDx of a fibroadenoma?

A

BENIGN:

  1. Fibroadenoma.
  2. Cyst.
  3. Fibrocystic changes.
  4. Galactocele.
  5. Fat necrosis, from trauma to breast.
  6. Abscess.

MALIGNANT:

  1. Infiltrating ductal breast carcinoma.
  2. Infiltrating lobular carcinoma.
  3. Mixed ductal/lobular carcinoma.
  4. Ductal carcinoma in situ.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Management and treatment of a fibroadenoma?

A
  1. Watchful waiting; 3-6 mo f/u w/repeat U/S and breast exam.
  2. Core needle biopsy.
  3. If Bx proven Fibroadenoma and asymptomatic, can be left in place (some women prefer to have it excised).
  4. Excision:
    - -Fibroadenoma > 3 cm.
    - -Increasing in size > 1 cm/yr.
    - -Bothersome (interfere w/ADLs or emotional stress).
  5. Cryoablation, alt Tx to surgical excision, only after core Bx diagnosis of fibroadenoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the most common breast condition in women of reproductive years?

A

Fibrocystic Changes.

*NOT associated with an increased risk of breast cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Fibrous tissue similar to scar tissue that is FIRM and RUBBERY, along w/fluid-filled sacs, mostly microscopic but can become macrocysts?

A

Fibrocystic changes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Epidemiology of fibrocystic changes?

A
  1. Peak incidence b/t 35-50 y/o.
  2. Influenced by hormonal function and fluctuation.
    - -Occurs during lobular development, menstrual cycle changes, and lobular involution in premenopausal and perimenopausal women.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What can fluctuating hormone levels during your menstrual cycle cause?

A

Breast discomfort and areas of lumpy breast tissue that feel tender, sore and swollen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the clinical presentation of fibrocystic changes?

A
  1. Particularly common in premenopausal women.
  2. Breast tissue more diffuse and tender; does not form a discrete or well-defined mass.
  3. May be cyclic or constant and may be bilateral, unilateral or focal. The breast tissue, particularity in the upper quadrant, may increase in size prior to menses then return to baseline after the onset of menstrual flow.
  4. On PE, breast tissue frequently is nodular.
29
Q

Evaluation and diagnostics of fibrocystic changes?

A
  1. H and P is the most important aspect of evaluation.
  2. Breast U/S can provide information about whether the breast cyst is simple, complicated and complex.
  3. Mammography.
  4. MRI.
30
Q

Differential diagnosis of fibrocystic changes?

A

Fibroadenoma, Cysts (simple and complex), Galactocele, Fat necrosis, breast abscess, malignancy.

31
Q

Management of fibrocystic changes?

A
  1. MOST cases require NO treatment and reassurance.
  2. If imaging obtained, most are BI-RADS2 (Benign) and do not warrant tissue diagnosis.
  3. Symptom relief:
    - -Warm compresses, well-fitting supportive bra, NSAIDs, reduce caffeine/stimulant intake.
  4. Routine f/u.
  5. Consider OCP to modulate Sx or to prevent development of new changes.
32
Q

What is the condition of benign proliferation of the glandular tissue of the male breast, which can be unilateral and bilateral?

A

Gynecomastia.

33
Q

What is the cause of Gynecomastia?

A

Due to an increase in the ratio of estrogen to androgen activity.

34
Q

Epidemiology of Gyncecomastia?

A
  1. Common in infancy, puberty and in middle-age to older men.
  2. Primary peak in infancy.
  3. Secondary peak during puberty.
    - -Onset b/t 10-12 yrs and peaks b/t 13-14, usually Tanner Stage 3.
  4. Tertiary peak occurs in middle-aged and older men.
35
Q

What percentage of Gynecomastia can persist into adulthood?

A

20%.

36
Q

When age group does the incidence of tertiary gynecomastia occur?

A

Highest prevalence at 50-80 yrs, with as many as many as 24-64% of men being affected.

37
Q

Risk factors for Gynecomastia?

A
  1. Persistent pubertal gynecomastia - 25%
  2. Drugs 10-25%.
  3. Idiopathic - 25%.
  4. Cirrhosis or malnutrition - 8%.
  5. Hypogonadism - Primary 8%, secondary 2%.
  6. Testicular tumors - 3%.
  7. Hyperthyroidism - 1.5%.
  8. CKD - 1%.
38
Q

Condition where breast enlargement is caused by fat accumulation?

A

Pseudogynecomastia.

39
Q

What is the clinical presentation of Gynecomastia?

A
  1. Usually found incidentally.
  2. Adolescents may present w/PAINFUL, TENDER Gynecomastia.
  3. PE in true Gynecomastia, a ridge of glandular tissue will be felt that is symmetrical to the nipple-areolar complex.
  4. Can usually be detected when the size of the glandular tissue exceeds 0.5 cm in diameter.
    - -Centrally located, symmetrical in shape, usually bilateral and tender to palpation (during the early growth phase).
40
Q

Evaluation of Gynecomastia?

A
  1. History!
  2. Review meds, OTC meds, dietary supps and herbal products.
  3. Review Hx for Sx of liver and kidney disease, overt hyperthyroidism and hypogonadism.
  4. Imaging is not routinely recommended unless concern for breast cancer.
  5. Usual imaging – mammography and U/S.
    - -U/S most specific.
    - -Mammo difficult to perform unless significant gynecomastia; is the most sensitive modality.
41
Q

What is the main PE finding of gynecomastia?

A

A concentric, rubbery to firm disk of tissue, often mobile; and located directly beneath the areolar area.

42
Q

When is there a concern for breast cancer in Gynecomastia evaluation?

A

With a new onset or rapid growth of a unilateral, nontender, and/or fixed mass that is ECCENTRIC to an areola.

43
Q

When is Biochemical Testing or hormone testing necessary in the evaluation of Gynecomastia?

A
  1. If the gynecomastia is of RECENT ONSET, is PAINFUL or TENDER, or is GREATER than 5 cm – serum hCG, FSH, LH, Testosterone and estradiol should be evaluated for tumors.
  2. In Middle-age to older men – morning serum total testosterone – repeat if low – if low, then order FSH, LH.
44
Q

DDx of Gynecomastia?

A
  1. Pseudogynecomastia.

2. Breast cancer.

45
Q

Management of Gynecomastia?

A
  1. Watchful waiting – recent onset often regresses spontaneously.
  2. D/C of medications.
  3. Early medical therapy
    - -Significant breast enlargement >4 cm in young men.
    - -Pain, tenderness, cosmetic concerns.
  4. Surgical intervention with persistent gynecomastia.
    - -Surgery effectively removes excess breast tissue at any time.
46
Q

What condition is defined as nonpathologic nipple discharge unrelated to pregnancy or breast feeding?

A

Galactorrhea or Physiologic nipple discharge.

47
Q

What is the 3rd most common breast-related complaint, after breast pain and breast mass?

A

Galactorrhea; up to 80% of women will have an episode of nipple discharge.

48
Q

What must galactorrhea be differentiated from?

A

Galactorrhea (benign nipple discharge) must be differentiated from an underlying papilloma, high-risk lesion or cancer.

49
Q

What are the risk factors for Galactorrhea?

A
  1. Age is predictive of the risk of cancer w/nipple discharge.
  2. Malignancy in women:
    - -3% under < 40, 10% of those age 40-60 yrs, and 32% of those age over 60 yrs.
  3. In men, nipple discharge is associated with an even higher incidence of breast cancer (23-57%), which may be their only clinical manifestation.
50
Q

What is the clinical presentation of Galactorrhea?

A

Nipple discharge.

51
Q

What is the most helpful in distinguishing physiologic from pathologic nipple discharge?

A

HISTORY!

  • Bloody vs Nonbloody, frequency, spontaneous or provoked, unilateral vs bilateral, uniductal vs multiductal.
  • Hx of recent trauma.
  • Recent onset of amenorrhea or other Sx of hypogonadism = hyperprolactinemia.
  • Med history.
52
Q

What indicates breast imaging and possible pathologic discharge of Galactorrhea?

A
  1. Unilateral nipple discharge.
  2. Blood nipple discharge.
  3. Nipple discharge associated with a mass or skin lesion.
53
Q

Diagnostic evaluation of physiologic discharge?

A
  1. Bilateral and NONbloody.
  2. Possible eval for Hyperprolactinemia.
  3. No specific imaging.
  4. Lab eval – preg test, prolactin levels, renal and TFTs.
  5. Consider endo referral.
54
Q

What is the first line imaging if indicated in the evaluation of Galactorrhea?

A
  1. Mammography.
  2. U/S provides a useful tool for Dx of ductal disease.
  3. MRI for pt’s with pathologic nipple discharge but negative mammo and U/S.
55
Q

DDx of Galactorrhea?

A
  1. Physiologic nipple discharge often caused by hyperprolactinemia.
  2. Breast cancer – invasive ductal cancer, papillary cancer, or ductal carcinoma in situ.
  3. No identifiable lesion.
56
Q

Management of Galactorrhea?

A
  1. D/C offending medication.
  2. Tx of other causes of hyperprolactinemia.
  3. Transient idiopathic galactorrhea (w/normal prolactin levels) can also occur, usually premenopausal women and can be reassessed in 2-3 months.
  4. For non-lactating women or men with pathologic nipple discharge – surgical mgmt depending on the result of the imaging studies and biopsy.
57
Q

What condition involves inflammation of the breast tissue that may or may not be accompanied by infection?

A

Mastitis.

*Mastitis does not necessarily occur during lactation, is not always accompanied by microbial infection and may not resolve with Abx.

58
Q

What is the epidemiology of Mastitis?

A
  1. Est. to occur in 2-10% of breastfeeding women.
  2. The risk of recurrence of mastitis in women w/prior Hx of lactational mastitis is higher than in women with no prior history.
  3. MC in the 1st 3 months of breastfeeding.
59
Q

What are the risk factors associated with Mastitis?

A

*Lactational mastitis often occurs in the setting of the below breastfeeding problems, which typically present in prolonged engorgement or poor drainage.

  • Partial blockage of milk duct (reduced drainage results in stagnant milk distal to the obstruction).
  • Oversupply of milk, infrequent feedings, nipple excoriation or cracking, rapid weaning, illness in mother or baby, maternal stress or excessive fatigue, maternal malnutrition.

*Prior Hx of mastitis, poor milk drainage, cracked nipples, use of cream on nipples (antifungal cream) and using a breast pump.

60
Q

Clinical presentation of Mastitis?

A
  1. Breast becomes painful and swollen.
  2. Engorgement occurs because of poor milk drainage.
  3. If Sx persist beyond 12-24 hrs, infective lactational mastitis develops.
  4. Reactive Lymphadenopathy – check the axilla and epitrochlear LNs.
61
Q

What happens if symptoms of mastitis persist beyond 12-24 hrs?

A

The condition of infective lactational mastitis develops since breast milk contains bacteria.
**Firm, red, painful, swollen area of one breast associated with fever >38.3C and a nursing mother, milk secretion may be diminished, myalgia, chills, malaise, and flu-like symptoms.

62
Q

Diagnostic evaluation of mastitis?

A
  1. Diagnosis is based on clinical manifestations; lab tests not needed.
  2. Culture of the breast milk can be useful to guide selection of Abx.
  3. Blood cultures.
  4. Imaging is useful if lactational mastitis does not respond within 48-72 hrs to supportive care and Abx.
63
Q

When are blood cultures indicated in the evaluation of mastitis?

A

In the setting of severe infection – hemodynamic instability, progressive erythema.

64
Q

What is the most effective method of differentiating mastitis from a breast abscess?

A

U/S.

65
Q

DDx of Mastitis?

A
  1. Severe engorgement.
  2. Breast abscess.
  3. Plugged duct.
  4. Galactocele.
  5. Inflammatory breast cancer – should be considered if mastitis does not resolve with appropriate treatment.
66
Q

How can lactational mastitis be reduced?

A

By frequent, complete emptying of the breast and by optimizing breastfeeding techniques.

67
Q

What is the most common cause of Infective Lactational mastitis?

A
  1. Most episodes cause by Staphylococcus Aureus.

2. MRSA has also become an important pathogen.

68
Q

Describe the management of mastitis?

A
  1. Sx treatment to reduce pain and swelling (NSAIDs, cold compress) and complete emptying of the breast; cessation of lactation is not required.
  2. Mgmt of infective Lactational mastitis – Abx therapy.
  3. No clinical improvement within 48-72 hrs, eval with U/S to determine if there is an underlying abscess should be pursued.
69
Q

What is the antibiotic management of mastitis?

A

Abx therapy should cover Staph Aureus.

  • NONSevere Infection in absence of RFs for MRSA – Dicloxacillin or Cephalexin (Clindamycin or Erythromycin).
  • NONSevere infection with risk for MRSA – Bactrim (if no breastfeeding) or Clindamycin.
  • Severe infection – Vancomycin.
  • Tx for 10-14 days, shorter courses (5-7) if response to therapy is rapid and complete.

OB/Gyn (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions